ARWR vs GM · rev $829.4M vs P/E 7.5, rev $91.65B
Arrowhead Pharmaceuticals Inc (ARWR) versus General Motors Company (GM) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
General Motors Company (GM) is a auto manufacturers company listed on US. It is led by Mary Barra.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported GM revenue for 2026-06-30 was $91.65B. Net income was $3.93B. GM currently screens at market cap $51.33B and trailing P/E 7.5.
ARWR currently screens at market cap $10.59B. GM currently screens at market cap $51.33B and trailing P/E 7.5.
Not investment advice. Open the ARWR and GM stock pages for the full models.
Not investment advice.